MedPath

The change of ocular biometry in ophthalmic patients who received anti-VEGF therapy

Not Applicable
Recruiting
Conditions
Patients with vitreoretinal diseases who need anti-VEGF therapy
Registration Number
JPRN-UMIN000031895
Lead Sponsor
Department of Ophthalmology, Faculty of Medicine, University of Tsukuba
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients ruled unfit to the study by investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
axial length, degree of crystalline lens opacity, functional visual acuity, contrast sensitivity, stereoscopic vision, metamorphopsia, color vision, microperimetry, retinal form, corneal biometry, VFQ-25
Secondary Outcome Measures
NameTimeMethod
visual acuity, intraocular pressure, frequency and degree of anti-VEGF injection complex
© Copyright 2025. All Rights Reserved by MedPath